Abstract
This chapter briefly summarizes what we currently know about some of the biological changes that accompany aging, and then tries to predict which of these may be the most relevant to the onset of age-related cardiac pathology, and the ultimate need for cardiothoracic surgery in older persons. Although cardiovascular diseases are now the major cause of mortality in developed countries, and age is a major risk factor for many of these diseases, it is still not clear just which age-related changes are the most critical in affecting longevity or the risk of dying as a result of cardiovascular pathology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
McCay CM, Crowell MF, Maynard LA. The effect of growth upon the length of life span and upon ultimate body size. J Nutr. 1935;10:63–75.
Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956;2:298–300.
Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res. 1965;37:614–35.
Weindruch R, Walford RL. The retardation of aging and disease by dietary restriction. Springfield, IL: Charles C. Thomas; 1988.
Lane MR, Ingram DK, Roth GS. Nutritional modulation of aging in nonhuman primates. J Nutr Health Aging. 1999;3:69–76.
Colman RJ, Anderson RM, Johnson SC, et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009;325:201–4.
Heilbronn LK, de Jonge L, Frisard MI, et al. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals. JAMA. 2006;295:1539–48.
Sinclair DA, Howitz KT. Dietary restriction, hormesis, and small molecule mimetics. In: Masoro EJ, Austad SN, editors. Handbook of the biology of aging. 6th ed. New York, NY: Academic Press; 2006. p. 63–104.
Masoro EJ. Caloric restriction and aging: an update. Exp Gerontol. 2000;35:299–305.
Murakami S, Salmon A, Miller RA. Multiplex stress resistance in cells from long-lived dwarf mice. FASEB J. 2003;17:1565–6.
Cohen HY, Miller C, Bitterman KJ, et al. Calorie restriction promotes mammalian survival by inducing the SIRT1 deacetylase. Science. 2004;305:390–2.
Tissenbaum HA, Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature. 2001;410:227–30.
Campisi J, Vijg J. Does damage to DNA and other macromolecules play a role in aging? If so, how? J Gerontol. 2009;64A:175–8.
Stadtman ER. Protein oxidation and aging. Science. 1992;257:1220–4.
Hamilton ML, Van Remmen H, Drake JA, et al. Does oxidative damage increase with age? Proc Natl Acad Sci USA. 2001;98:10469–74.
Ciechanover A. Proteolysis: from the lysosome to ubiquitin to the proteosome. Nat Rev Mol Cell Biol. 2005;6:79–86.
Cuervo AM. Calorie restriction and aging: the ultimate cleansing diet. J Gerontol. 2008;63A:547–9.
Pamplona R, Portero-Otin M, Sanz A, et al. Modification of the longevity-related degree of fatty acid unsaturation modulates oxidative damage to proteins and mitochondrial DNA in liver and brain. Exp Gerontol. 2004;39:725–33.
Pamplona R. Membrane phospholipids, lipoxidative damage, and molecular integrity: a causal role in aging and longevity. Biochim Biophys Acta. 2008;1777:1249–62.
Friguet B, Szweda L. Inhibition of the multicatalytic proteinase (proteosome) by 4-hydroxy-2-nonenal cross-linked protein. FEBS Lett. 1997;405:21–5.
Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345:458–60.
Blackburn EH, Greider CW, Henderson E, et al. Recognition and elongation of telomeres by telomerase. Genome. 1989;31:553–60.
Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal cells. Science. 1998;279:349–52.
Blasco MA. Telomere length, stem cells and ageing. Nat Chem Biol. 2007;3:640–7.
Krtolica A, Parrinello S, Lockett S, et al. Senescent fibroblasts promote epithelial growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA. 2001;98:12072–7.
Sedivy J. Telomeres limit cancer growth by inducing senescence: long sought in vivo evidence obtained. Cancer Cell. 2007;11:389–91.
Wright WE, Piatyszek MA, Rainey WE, et al. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet. 1996;18:173–9.
Liu K, Schoonmaker MM, Levine BL, et al. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc Natl Acad Sci USA. 1999;96:5147–52.
Holt SE, Wright WE, Shay JW. Regulation of telomerase activity in immortal cell lines. Mol Cell Biol. 1996;16:2932–9.
Sharpless NE, DePinho RA. How stem cells age and why this makes us old. Nat Rev Mol Cell Biol. 2007;8:703–12.
Tomas-Loba A, Flores I, Fernandez-Marcos J, et al. Telomerase reverse transcriptase delays aging in cancer-resistant mice. Cell. 2008;135:609–22.
Ogami M, Ikura Y, Ohsawa M, et al. Telomere shortening in human coronary heart disease. Arterioscler Thromb Vasc Biol. 2004;24:546–50.
Friedman DB, Johnson TE. A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics. 1988;118:75–86.
Morris J, Tissenbaum H, Ruvkun G. A phosphatidylinositol-3 OH kinase family member regulates longevity and diapause in Caenorhabditis elegans. Nature. 1996;382:536–9.
Kenyon C, Chang C, Genesch E, et al. A C. elegans mutant that lives twice as long as wild type. Nature. 1993;366:461–4.
Kimura D, Tissenbaum HA, Liu Y, Ruvkun G. daf-2, An insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science. 1997;277:942–6.
Warner HR. Longevity genes: from primitive organisms to humans. Mech Ageing Dev. 2005;126:235–42.
Murphy CT, McCarroll SA, Bargmann CI, et al. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature. 2003;424:277–84.
Wolff S, Dillin A. The trifecta of aging in Caenorhabditis elegans. Exp Gerontol. 2006;41:894–903.
Sarbassov DD, Ali SM, Sabatini DA. Growing roles of the mTOR pathway. Curr Opin Cell Biol. 2005;17:596–603.
Vellai T, Takacs-Vellai K, Zhang Y, et al. Influence of TOR kinase on lifespan in C. elegans. Nature. 2003;426:620.
Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460:392–5.
Kaeberlein M, Powers R, Steffen K, et al. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science. 2005;310:1193–6.
Stanfel MN, Shamich LS, Kaeberlein M, Kennedy BK. The TOR pathway comes of age. Biochim Biophys Acta. 2009;1790:1067–74.
Haigis MC, Guarente LP. Mammalian sirtuins – emerging roles in physiology, aging and calorie restriction. Genes Dev. 2006;20:2913–21.
Howitz KT, Bitterman KJ, Cohen HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003;425:191–6.
Brown-Borg HM, Borg KE, Meliska CJ, Bartke A. Dwarf mice and the ageing process. Nature. 1996;384:33.
Bartke A, Wright JC, Mattison JA, et al. Extending the life span of long-lived mice. Nature. 2001;414:412.
Nemoto S, Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science. 2002;295:2450–2.
Migliaccio E, Giorgio M, Mele S, et al. The p66shc adapter protein controls oxidative stress response and life span in mammals. Nature. 1999;402:309–13.
Conover CA, Bale LK. Loss of pregnancy-associated plasma protein A extends life span in mice. Aging Cell. 2007;6:727–9.
Walker GA, Lithgow GJ. Lifespan extension in C. elegans by a molecular chaperone dependent upon insulin-like signals. Aging Cell. 2003;2:131–9.
Mishkin R, Masos T. Transgenic mice over-expressing urokinase-type plasminogen activator in brain exhibit reduced food consumption, body weight and size, and increased longevity. J Gerontol. 1997;52:B118–24.
Conboy IM, Rando TA. Aging, stem cells and tissue regeneration: lessons from muscle. Cell Cycle. 2005;4:407–10.
Sharpless NE, Schatten G. Stem cell aging. J Gerontol. 2009;64A:202–4.
Warner HR. Is cell death and replacement a factor in aging. Mech Ageing Dev. 2007;128:13–6.
Jilka RL, Weinstein RS, Parfitt AM, Manolagas SC. Quantifying osteoblast and osteocyte apoptosis: challenges and rewards. J Bone Miner Res. 2007;22:1492–501.
Dimri GP, Lee X, Basile G, et al. A novel biomarker identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA. 1995;92:9363–7.
Vaupel JW, Kistowski KG. The remarkable rise in life expectancy and how it will affect medicine. Bundesgesundheitsblatt Gesundheitforschung Gesundheitsschutz. 2005;48:586–92.
Perez VI, Bokov A, Van Remmen H, et al. Is the oxidative stress theory of aging dead? Biochim Biophys Acta. 2009;1790:1005–14.
Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infracted myocardium. Pediatr Transplant. 2003;7 Suppl 3:86–8.
Katsjura J, Rota M, Urbanek K, et al. The telomere-telomerase axis and the heart. Antioxid Redox Signal. 2006;8:2125–41.
Kajstura J, Urbanek K, Rota M, et al. Cardiac stem cells and myocardial disease. J Mol Cell Cardiol. 2008;45:505–13.
Torella D, Rota M, Nurzynska D, et al. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res. 2004;94:514–24.
Mitchell JR, Wood E, Collins KA. A telomerase component is defective in the human disease dyskeratosis congenita. Nature. 1999;402:551–5.
Vulliamy T, Marrone A, Szydlo R, et al. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet. 2004;36:447–9.
Espejel S, Klatt P, Menissier-de Murcia J, et al. Impact of telomerase ablation on organismal viability, aging and tumorigenesis in mice lacking the DNA repair proteins PARP-1, Ku86, or DNA-PKcs. J Cell Biol. 2004;167:627–38.
Oh H, Wang SC, Prahash A, et al. Telomere attrition and Chk2 activation in human heart failure. Proc Natl Acad Sci USA. 2003;100:5378–83.
Leri A, Franco S, Zacheo A, et al. Ablation of telomerase and telomere loss leads to cardiac dilation and heart failure associated with p53 upregulation. EMBO J. 2003;22:131–9.
Chang S, Multani AS, Cabrera NG, et al. Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat Genet. 2004;36:877–82.
Miller RA. Kleemeier award lecture: are there genes for aging? J Gerontol. 1999;54A:B297–307.
Coschigano KT, Holland AN, Riders ME, et al. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin growth factor I levels and increased life span. Endocrinology. 2003;144:3799–810.
Schriner SE, Linford NJ, Martin GM, et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science. 2005;308:1909–11.
Kuro-o M. Klotho and aging. Biochim Biophys Acta. 2009;1790:1049–58.
Seo AY, Xu J, Servais S, et al. Mitochondrial iron accumulation with age and functional consequences. Aging Cell. 2008;7:706–16.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Warner, H.R. (2011). Biology of Aging. In: Katlic, M. (eds) Cardiothoracic Surgery in the Elderly. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0892-6_15
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0892-6_15
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0891-9
Online ISBN: 978-1-4419-0892-6
eBook Packages: MedicineMedicine (R0)